eMediWrite

AUGUST 2, 2023

Governments have responded by implementing more stringent guidelines for the approval of new products. Globally, market access has drawn a lot of attention as nations struggle to control their rising healthcare costs amid the international economic downturn.

Marketing 52

Marketing Management Key account management Healthcare 52

Clarity Engagement Solutions

NOVEMBER 9, 2020

the evolving healthcare industry, pharma and bio-tech companies are now focusing on each component of market access: – Price – Channel – Stakeholders – Government agencies How do these elements apply to new types of decision makers, previously unknown to market access teams?

Marketing 91

Marketing Key account management Pharma Prescription 91

Clarity Engagement Solutions

NOVEMBER 9, 2020

– Government agencies. A survey conducted by Cegedim revealed that Key Account Management (KAM) was the technique that procured the best results for market access strategies. Thus, market access involved little engagement with a small set of stakeholders.In – Channel. – Stakeholders.

Marketing 91

Marketing Key account management Pharma Prescription 91

Clarity Engagement Solutions

NOVEMBER 9, 2020

There’s a reason why stakeholders in ONE ecosystem setting, (payers and government health authorities) want Pharma to understand concerns around care protocols and costs in a SECOND ecosystem setting, (hospitals, HCPs and provider decision makers).

Pharma 91

Pharma Healthcare Healthcare Distribution 91

pharmaphorum

DECEMBER 23, 2022

Companies that adopt this blended model will be able to recognise performance gaps earlier and, for the first time, align incentives across the entire commercial ecosystem, including sales reps, key account managers, and medical science liaisons.”. Content automation will deliver as AI fails to live up to the hype.

Marketing 90

Marketing Sales Medical Patients 90

Evolve Your Success

JANUARY 31, 2023

You have to be able to talk about your product, especially in our field because it’s so governed by the FDA. Most people come into the sales process with the belief system that selling is talking about my product. That is true. It’s litigious. We’re restricted. There’s so much oversight.

Medical sales 64

Medical sales Sales Medical Training 64